N-Formimidoyl Thienamycin (MK0787): In Vitro Activity Against Anaerobic Bacteria.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.21.1.168
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Activity of N-Formimidoyl Thienamycin (MK0787), a Crystalline Derivative of Thienamycin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1980English

In Vitro Activity of MK0787 (N-Formimidoyl Thienamycin) and Other Beta-Lactam Compounds Against Bacteroides Spp.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1981English

Activity of N-Formimidoyl Thienamycin and Cephalosporins Against Isolates From Nosocomially Acquired Bacteremia.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1982English

In Vitro Activity of N-Formimidoyl Thienamycin in Comparison With Cefotaxime, Moxalactam, and Ceftazidime.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1981English

Comparative in Vitro Activities of N-Formimidoyl Thienamycin and Moxalactam Against Nonfermentative Aerobic Gram-Negative Rods

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1982English

In Vitro Activity of Cefbuperazone Against Anaerobic Bacteria.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

A Comparison of the Antibacterial Activities of N-Formimidoyl Thienamycin (MK0787) With Those of Other Recently Developed Beta-Lactam Derivatives.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1982English

In Vitro Activity of FK037, a New Parenteral Cephalosporin, Against Anaerobic Bacteria.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1993English

Comparative in Vitro Activity of Cefbuperazone Against Anaerobic Bacteria Isolated From Community Hospitals.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy